Monsanto (MON +1.3%) moves higher following a Bloomberg report that Bayer (OTCPK:BAYRY) is exploring the sale of its dermatology business, as the German company seeks to sell peripheral businesses to boost its pursuit of MON.
The business could attract interest from existing makers of skincare products such as Nestle’s (OTCPK:NSRGY, OTCPK:NSRGF) Galderma, Allergan (NYSE:AGN) and Almirall (OTC:LBTSF) of Spain, as well as P-E firms, according to the report.
LEA TAMBIÉN: Finanzas: Colgate-Palmolive declares $0.39 dividend
Analysts say a sale of the unit could fetch more than €1B ($1.1B).
Fuente: Seeking Alpha
Reciba las últimas noticias de la industria en su casilla: